NEW YORK, Aug. 7 – Gene Logic spinoff Metrigenix announced on Tuesday its first deal, saying it would work with Neuralstem to co-develop low-density oligonucleotide microarrays designed to study gene expression in the central nervous system.

Metrigenix will provide its Flow-thru Chip technology, while privately held Neuralstem, a developer of stem-cell technology for the human central nervous system, will contribute the content.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.